首页> 美国卫生研究院文献>PLoS Clinical Trials >Label-Free Enrichment of Functional Cardiomyocytes Using Microfluidic Deterministic Lateral Flow Displacement
【2h】

Label-Free Enrichment of Functional Cardiomyocytes Using Microfluidic Deterministic Lateral Flow Displacement

机译:使用微流确定性侧向血流位移的功能性心肌细胞的无标签富集

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Progress in cardiac cell replacement therapies and tissue engineering critically depends on our ability to isolate functional cardiomyocytes (CMs) from heterogeneous cell mixtures. Label-free enrichment of cardiomyocytes is desirable for future clinical application of cell based products. Taking advantage of the physical properties of CMs, a microfluidic system was designed to separate CMs from neonatal rat heart tissue digest based on size using the principles of deterministic lateral displacement (DLD). For the first time, we demonstrate enrichment of functional CMs up to 91±2.4% directly from the digested heart tissue without any pre-treatment or labeling. Enriched cardiomyocytes remained viable after sorting and formed contractile cardiac patches in 3-dimensional culture. The broad significance of this work lies in demonstrating functional cell enrichment from the primary tissue digest leading directly to the creation of the engineered tissue.
机译:心脏细胞替代疗法和组织工程学的进展关键取决于我们从异质细胞混合物中分离功能性心肌细胞(CM)的能力。对于基于细胞的产品的未来临床应用,期望心肌细胞的无标记富集。利用CM的物理特性,设计了一种微流体系统,使用确定性侧向位移(DLD)原理,根据大小将CM与新生大鼠心脏组织消化液分离。首次,我们证明了从消化的心脏组织直接富集高达91±2.4%的功能性CM,无需任何预处理或标记。富集的心肌细胞经过分选后仍保持活力,并在3维培养物中形成收缩性心肌斑块。这项工作的广泛意义在于,从主要组织消化中证明功能性细胞富集可直接导致工程组织的产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号